You just read:

Neurofibromatosis Therapeutics Pipeline Analysis 2018: Key Players are Novartis, AstraZeneca, Pfizer, GlaxoSmithKline, Merck & Co & BioXcel Therapeutics

News provided by

Research and Markets

Mar 27, 2018, 07:30 ET